Rockefeller Financial Services’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
– Sell
-825
Closed -$18K – 498
2014
Q3
$18K Hold
825
– – ﹤0.01% 434
2014
Q2
$17K Hold
825
– – ﹤0.01% 485
2014
Q1
$18K Hold
825
– – ﹤0.01% 461
2013
Q4
$17K Sell
825
-1
-0.1% -$19 ﹤0.01% 445
2013
Q3
$16K Buy
826
+15
+2% +$287 ﹤0.01% 454
2013
Q2
$14K Buy
+811
New +$14.6K ﹤0.01% 455

Other funds holding HQL

Rockefeller Financial Services's HQL Position: Q4 2014 in Review

Rockefeller Financial Services sold out of abrdn Life Sciences Investors (HQL) in Q4 2014, closing a stake of 825 shares — an estimated $18K sold.

Rockefeller Financial Services first reported a position in HQL in Q2 2013 and held it in 6 quarters. The position peaked at $18K in Q3 2014. 45 funds tracked by Wall St. Rank hold HQL as of Q4 2014.

  • Rockefeller Financial Services reported no remaining abrdn Life Sciences Investors position as of Q4 2014 after selling out during the quarter.
  • Rockefeller Financial Services sold 825 abrdn Life Sciences Investors shares in Q4 2014, an estimated $18K.
  • Rockefeller Financial Services first reported a position in abrdn Life Sciences Investors in Q2 2013 and held it in 6 quarters.
  • Rockefeller Financial Services's abrdn Life Sciences Investors position peaked at $18K in Q3 2014.
  • 45 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2014.

Based on Rockefeller Financial Services's 13F filing for Q4 2014, filed 28 Jan 2015.